Responsible Translational Pathways for Germline Gene Editing?
Work on this paper was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R03HG010417. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.
Current Stem Cell Reports
Continued development of gene editing techniques has raised the real possibility of clinical application of germline gene editing. These results, as well as reports of an unethical experiment which resulted in the birth of at least two children from edited embryos in 2018, have highlighted the urgency and importance of ethical issues about translational pathways for editing of human germline cells. Charting responsible translational pathways for germline gene editing requires tackling some significant and complex ethical issues.
Locate the Document
Cwik, B. (2020). Responsible Translational Pathways for Germline Gene Editing? Current Stem Cell Reports. https://doi.org/10.1007/s40778-020-00179-x